Form 8-K - Current report:
SEC Accession No. 0000950170-24-113210
Filing Date
2024-10-07
Accepted
2024-10-07 16:05:08
Documents
14
Period of Report
2024-10-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atha-20241001.htm   iXBRL 8-K 56328
2 EX-10.1 atha-ex10_1.htm EX-10.1 106570
3 EX-10.2 atha-ex10_2.htm EX-10.2 228778
4 GRAPHIC img61222073_0.jpg GRAPHIC 828220
  Complete submission text file 0000950170-24-113210.txt   1716290

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atha-20241001.xsd EX-101.SCH 26991
16 EXTRACTED XBRL INSTANCE DOCUMENT atha-20241001_htm.xml XML 4888
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39503 | Film No.: 241357824
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)